The Analyst Conundrum: Up or Down?
ChampionX Corp (CHX) has surged above the average analyst 12-month target price of $36.75, hitting $39.08 per share. When a stock breaches its target, analysts stand at a crossroads: to lower the bar due to valuation concerns or upscale the goalpost.
The Array of Analyst Targets
Within the Zacks coverage universe, 8 analysts paint a diverse picture for ChampionX Corp. While the average target stands at $36.75, there are outliers – one with a bearish $32.00 target and another with a bullish $40.00 projection. The standard deviation lies at $3.494.
The Wisdom of Crowds in Action
The concept of average target prices attempts to tap into the collective wisdom of various analysts, rather than relying solely on one expert’s opinion. With CHX surpassing the defined mark, investors are prompted to reassess the company’s trajectory. Is $36.75 a pit stop on the road to a loftier target, or is it a sign to cash in some chips?
Recent CHX Analyst Ratings Breakdown | ||||
---|---|---|---|---|
» | Current | 1 Month Ago | 2 Month Ago | 3 Month Ago |
Strong buy ratings: | 6 | 6 | 6 | 7 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 2 | 2 | 2 | 1 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.5 | 1.5 | 1.5 | 1.25 |
The rating scale ranges from 1 (Strong Buy) to 5 (Strong Sell), providing a snapshot of analyst sentiment. Data sourced from Zacks Investment Research via Quandl.com.
Check out: 10 ETFs With Most Upside To Analyst Targets »
Further Exploration:
• ARSD Videos
• PFDR shares outstanding history
• ALOR shares outstanding history
The opinions expressed are those of the author and may not align with Nasdaq, Inc.